https://www.webwire.com/ViewPressRel.asp?aId=9072
Bristol-Myers Squibb Company And Otsuka Pharmaceutical Co., Ltd. Announce Availability Of 2 mg...
Newly Available Options Equip Physicians with Increased Flexibility when Customizing Treatment to Address Specific Needs of Adults with Schizophrenia or...
bristol myers squibb company
https://www.biospace.com/otsuka-pharmaceutical-co-ltd-release-b-chmp-b-recommends-jinarc-tolvaptan-for-approval-in-eu-the-first-pharmaceutical-treatment-for-autosoma
Otsuka Pharmaceutical Co., Ltd. Release: CHMP Recommends Jinarc (Tolvaptan) For Approval In EU: The...
otsuka pharmaceutical co ltd
https://www.otsuka.co.jp/en/
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical is a holistic healthcare company contributing to people's health worldwide through two core businesses: pharmaceuticals and...
otsuka pharmaceutical coltd